Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mizuno

Showing results (171-180 of 228) with videos related to

Pageof 23
Sort By:
Anticancer Research|May 1, 1997
Antitumor mechanism of intradermal administration of lipopolysaccharideH Inagawa, T Nishizawa, K Takagi, et al.
Journal of Virology|June 1, 1989
Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replicationT Matsuyama, Y Hamamoto, G Soma, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1991
Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumorsK Noguchi, H Inagawa, Y Tsuji, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 1, 1984
[Induction and potentiation of phagocyte-mediated tumor lysis by chemotherapeutic drugs for cancer]M Yamazaki, M Ikenami, J Kisugi, et al.
In Vivo (Athens, Greece)|March 1, 1995
Early embryonic cells activate the alternative complement systemR Kircheis, L Kircheis, H Oshima, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 1, 1985
[Induction of cytotoxic activity in sera by immunomodulators]K Takahashi, J Kisugi, T Gatanaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1987
[Partial response of lung metastases from a renal cancer treated with endogenous tumor necrosis factor]M Kato, D Ishiwata, R Kakehi, et al.
In Vivo (Athens, Greece)|July 1, 1996
Selective lysis of early embryonic cells by the alternative pathway of complement--a possible mechanism for programmed cell death in embryogenesisR Kircheis, L Kircheis, H Oshima, et al.
Journal of Biological Response Modifiers|December 1, 1990
Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factorT Okutomi, H Inagawa, T Nishizawa, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1988
Endogenous tumor necrosis factor induction with Bordetella pertussis vaccine as a triggering agent and its therapeutic effect on MM46 carcinoma-bearing miceH Minagawa, Y Kakamu, H Yoshida, et al.
Pageof 23

Showing results (171-180 of 228) with videos related to

Sort By:
Pageof 23
Anticancer Research|May 1, 1997
Antitumor mechanism of intradermal administration of lipopolysaccharideH Inagawa, T Nishizawa, K Takagi, et al.
Journal of Virology|June 1, 1989
Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replicationT Matsuyama, Y Hamamoto, G Soma, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1991
Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumorsK Noguchi, H Inagawa, Y Tsuji, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 1, 1984
[Induction and potentiation of phagocyte-mediated tumor lysis by chemotherapeutic drugs for cancer]M Yamazaki, M Ikenami, J Kisugi, et al.
In Vivo (Athens, Greece)|March 1, 1995
Early embryonic cells activate the alternative complement systemR Kircheis, L Kircheis, H Oshima, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 1, 1985
[Induction of cytotoxic activity in sera by immunomodulators]K Takahashi, J Kisugi, T Gatanaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1987
[Partial response of lung metastases from a renal cancer treated with endogenous tumor necrosis factor]M Kato, D Ishiwata, R Kakehi, et al.
In Vivo (Athens, Greece)|July 1, 1996
Selective lysis of early embryonic cells by the alternative pathway of complement--a possible mechanism for programmed cell death in embryogenesisR Kircheis, L Kircheis, H Oshima, et al.
Journal of Biological Response Modifiers|December 1, 1990
Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factorT Okutomi, H Inagawa, T Nishizawa, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1988
Endogenous tumor necrosis factor induction with Bordetella pertussis vaccine as a triggering agent and its therapeutic effect on MM46 carcinoma-bearing miceH Minagawa, Y Kakamu, H Yoshida, et al.
Pageof 23